Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-24455

Single-particle
3.0 Å
EMD-24455
3D View Gallery
Deposition: 16/07/2021
Map released: 04/08/2021
Last modified: 14/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-24455
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 7rh5 summary report (pdf.gz) Map and 7rh5 FULL report (pdf.gz)
EMICSS annotations (xml)

Mycobacterial CIII2CIV2 supercomplex, Inhibitor free

EMD-24455

Single-particle
3.0 Å
EMD-24455
3D View Gallery
Deposition: 16/07/2021
Map released: 04/08/2021
Last modified: 14/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155)
Sample: Respiratory supercomplex CIII2CIV2SOD2 from Mycobacterium smegmatis
Fitted models: 7rh5

Deposition Authors: Di Trani JM , Yanofsky DJ
Structure of mycobacterial CIII 2 CIV 2 respiratory supercomplex bound to the tuberculosis drug candidate telacebec (Q203).
Yanofsky DJ, Di Trani JM , Krol S, Abdelaziz R , Bueler SA, Imming P , Brzezinski P , Rubinstein JL
(2021) eLife , 10
PUBMED: 34590581
DOI: doi:10.7554/eLife.71959
ISSN: 2050-084X